SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Fermenta Biotech - Quaterly Results

11 Feb 2025 Evaluate
A decent increase of about 63.68% in the turnover to Rs. 1462.52 millions was observed for the quarter ended December 2024. The turnover stood at Rs. 893.51 millions during the similar quarter previous year.Net Profit witnessed a 199.20% growth almost the double from Rs. 116.97 millions to Rs. 349.98  millions  of same quarter last year.Operating profit for the quarter ended December 2024 rose to 523.58 millions as compared to 290.71 millions of corresponding quarter ended December 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 1462.52 893.51 63.68 3084.94 2174.35 41.88 3070.90 3289.14 -6.64
Other Income 22.20 25.77 -13.85 77.95 66.57 17.09 81.54 84.62 -3.64
PBIDT 523.58 290.71 80.10 752.35 347.19 116.70 451.40 468.98 -3.75
Interest 40.93 51.64 -20.74 112.09 136.37 -17.80 170.52 208.02 -18.03
PBDT 482.65 239.07 101.89 640.26 120.82 429.93 190.88 -334.93 -156.99
Depreciation 58.20 61.27 -5.01 175.75 174.96 0.45 236.96 244.85 -3.22
PBT 424.45 177.80 138.72 464.51 -54.14 -957.98 -46.08 -579.78 -92.05
TAX 74.47 60.83 22.42 81.47 60.83 33.93 141.36 -9.74 -1551.33
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 124.56 -11.56 -1177.51
PAT 349.98 116.97 199.20 383.04 -114.97 -433.17 -187.44 -570.04 -67.12
Equity 145.77 144.37 0.97 145.77 144.37 0.97 144.37 144.29 0.06
PBIDTM(%) 35.80 32.54 10.03 24.39 15.97 52.73 14.70 14.26 3.09

Fermenta Biotech Share Price

321.85 0.05 (0.02%)
16-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1693.15
Dr. Reddys Lab 1221.25
Cipla 1230.75
Zydus Lifesciences 939.20
Lupin 2326.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×